Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition

Luteolin is a naturally-occurring polyphenolic compound that is known to have antioxidative and antitumor activities in vitro. This study aimed to examine the in vivo anticancer efficacy of luteolin in conjunction with oxaliplatin treatment using a colorectal carcinoma xenograft mouse model. HCT116...

Full description

Saved in:
Bibliographic Details
Main Authors: Chan Ho Jang, Nayoung Moon, Jinkyung Lee, Min Jeong Kwon, Jisun Oh, Jong-Sang Kim
Format: Artigo
Language:Inglês
Published: MDPI AG 2022-03-01
Series:Antioxidants
Subjects:
luteolin
oxaliplatin
colorectal cancer
xenograft tumor
AMPK inhibition
Online Access:https://www.mdpi.com/2076-3921/11/4/626
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items